Walgreens Boots Alliance Statistics

Total Valuation

Walgreens Boots Alliance has a market cap or net worth of EUR 7.93 billion. The enterprise value is 39.10 billion.

Market Cap	7.93B
Enterprise Value	39.10B

Important Dates

The next estimated earnings date is Friday, January 3, 2025.

Earnings Date	Jan 3, 2025
Ex-Dividend Date	Nov 18, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	714.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.52, with an EV/FCF ratio of -119.14.

EV / Earnings	-5.01
EV / Sales	0.28
EV / EBITDA	5.52
EV / EBIT	38.10
EV / FCF	-119.14

Financial Position

The company has a current ratio of 0.68, with a Debt / Equity ratio of 2.78.

Current Ratio	0.68
Quick Ratio	0.33
Debt / Equity	2.78
Debt / EBITDA	4.73
Debt / FCF	-93.25
Interest Coverage	1.44

Financial Efficiency

Return on equity (ROE) is -75.97% and return on invested capital (ROIC) is 0.96%.

Return on Equity (ROE)	-75.97%
Return on Assets (ROA)	0.59%
Return on Capital (ROIC)	0.96%
Revenue Per Employee	528,703
Profits Per Employee	-30,922
Employee Count	312,000
Asset Turnover	1.66
Inventory Turnover	14.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.09% in the last 52 weeks. The beta is 0.68, so Walgreens Boots Alliance's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-61.09%
50-Day Moving Average	8.76
200-Day Moving Average	11.76
Relative Strength Index (RSI)	53.33
Average Volume (20 Days)	10,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.24

Income Statement

In the last 12 months, Walgreens Boots Alliance had revenue of EUR 133.50 billion and -7.81 billion in losses. Loss per share was -9.05.

Revenue	133.50B
Gross Profit	23.98B
Operating Income	758.54M
Pretax Income	-12.84B
Net Income	-7.81B
EBITDA	2.61B
EBIT	758.54M
Loss Per Share	-9.05

Full Income Statement

Balance Sheet

The company has 2.81 billion in cash and 30.60 billion in debt, giving a net cash position of -27.79 billion.

Cash & Cash Equivalents	2.81B
Total Debt	30.60B
Net Cash	-27.79B
Net Cash Per Share	n/a
Equity (Book Value)	11.01B
Book Value Per Share	10.93
Working Capital	-7.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 920.37 million and capital expenditures -1.25 billion, giving a free cash flow of -328.19 million.

Operating Cash Flow	920.37M
Capital Expenditures	-1.25B
Free Cash Flow	-328.19M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 17.96%, with operating and profit margins of 0.57% and -5.85%.

Gross Margin	17.96%
Operating Margin	0.57%
Pretax Margin	-9.62%
Profit Margin	-5.85%
EBITDA Margin	1.95%
EBIT Margin	0.57%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.92, which amounts to a dividend yield of 10.16%.

Dividend Per Share	0.92
Dividend Yield	10.16%
Dividend Growth (YoY)	-48.11%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	10.17%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Walgreens Boots Alliance has an Altman Z-Score of 2.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	n/a